Steven Cohen's TNXP Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 620,033 shares of Tonix Pharmaceuticals Holding Corp. (TNXP) worth $9.68 M, representing 0.01% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Steven Cohen has initiated a new position in TNXP, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Tonix Pharmaceuticals Holding (TNXP) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tonix Pharmaceuticals Holding (TNXP) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +620,033 | New Buy | 620,033 | $15.62 |
Steven Cohen's Tonix Pharmaceuticals Holding Investment FAQs
Steven Cohen first purchased Tonix Pharmaceuticals Holding Corp. (TNXP) in Q4 2025, acquiring 620,033 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Tonix Pharmaceuticals Holding Corp. (TNXP) for 1 quarters since Q4 2025.
Steven Cohen's largest addition to Tonix Pharmaceuticals Holding Corp. (TNXP) was in Q4 2025, adding 620,033 shares worth $9.68 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 620,033 shares of Tonix Pharmaceuticals Holding Corp. (TNXP), valued at approximately $9.68 M.
As of the Q4 2025 filing, Tonix Pharmaceuticals Holding Corp. (TNXP) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Tonix Pharmaceuticals Holding Corp. (TNXP) was 620,033 shares, as reported at the end of Q4 2025.